FDA Faces Pivotal Decision on First mRNA Flu Shot
#mRNA #FDAFDA weighs Moderna's mRNA flu shot amid RFK Jr.'s scrutiny, after a February rejection and reversal. Approval could boost mRNA research, but funding cuts and industry fears chill innovation, impacting patients like a cancer survivor. read more
Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk
#mRNA #MelanomaAn mRNA vaccine combined with Keytruda reduced melanoma recurrence risk by 49% in a trial. After five years, 68.8% of patients remained cancer-free. The personalized vaccine targets each patient's tumor, offering hope for preventing advanced skin cancer. read more